SCHEMBL7690766

SCHEMBL7690766

Cn1c(=O)c(-c2ccccc2Cl)nc2cnc(Nc3ccccc3)nc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.73
USP2 O75604 6/20 0.73
CASP7 P55210 4/20 0.73
MEN1 O00255 4/20 0.73
KMT2A Q03164 4/20 0.73
CYP2C19 P33261 3/20 0.73
CASP1 P29466 3/20 0.73
HIF1A Q16665 2/20 0.73
ALDH1A1 P00352 3/20 0.72
WEE1 P30291 10/20 0.67
CYP3A4 P08684 3/20 0.65
CYP2C9 P11712 3/20 0.65
CYP2D6 P10635 1/20 0.65
MAPK1 P28482 2/20 0.65
EGFR P00533 1/20 0.62
FGFR1 P11362 1/20 0.62
SRC P12931 1/20 0.62
FGFR2 P21802 1/20 0.62
FGFR4 P22455 1/20 0.62
FGFR3 P22607 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695096 0.90 EGFR (0.64) CYP1A2USP2CASP7MEN1KMT2A
SCHEMBL7694838 0.89 CYP1A2 (0.73) CYP1A2USP2CASP7MEN1KMT2A
SCHEMBL30878465 0.78 WEE1 (0.77) CYP1A2WEE1CYP3A4CYP2C9CYP2D6
SCHEMBL1249524 0.76 FGFR1 (1.00) WEE1EGFRFGFR1SRCFGFR2
SCHEMBL7689910 0.76 USP2 (0.81) CYP1A2USP2CASP7MEN1KMT2A
SCHEMBL5523042 0.74 SRC (0.74) CYP1A2USP2CASP7MEN1KMT2A
SCHEMBL20564683 0.74 FGFR1 (0.81) WEE1EGFRFGFR1SRCFGFR2
SCHEMBL29498213 0.74 FGFR1 (0.81) WEE1EGFRFGFR1SRCFGFR2
SCHEMBL25779595 0.73 WEE1 (1.00) WEE1EGFRFGFR1SRCFGFR2
SCHEMBL2245290 0.73 WEE1 (0.62) WEE1EGFRFGFR1SRCFGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076954-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES SMITHKLINE BEECHAM CORPORATION (US) 2002-10-03 WO disclosed